Exo Imaging Inc.

11/19/2026 | Press release | Distributed by Public on 11/19/2026 09:16

Exo Receives $11.6 Million Grant to Expand Access to AI-Powered Ultrasound

The funding will advance Exo's silicon and AI platform to bring affordable, real-time imaging to frontline workers, with support from the Gates Foundation.

Santa Clara, CA-November 19th, 2026 Exo (pronounced "echo") today announced an $11.6 million grant from the Gates Foundation to advance its next-generation technology and expand access to essential diagnostic imaging in low- and middle-income countries.

The funding will support development of an affordable, multi-use handheld ultrasound system that enables frontline healthcare workers without specialized ultrasound expertise to acquire and interpret images for essential diagnostics and risk screening.

The Exo platform integrates advanced silicon-based imaging hardware with AI that guides image acquisition and interpretation in real time. The AI runs directly on the device, without requiring an internet connection. The technology is designed to address key barriers to ultrasound access, including equipment costs, imaging complexity, specialist shortages, and unreliable connectivity.

"By combining silicon imaging with on-device AI, we're working to make ultrasound more affordable and easier for frontline healthcare workers to use," said Sandeep Akkaraju, CEO of Exo. "This funding will help us advance a platform designed for communities where access to imaging and specialist expertise is limited. We're grateful to the Gates Foundation for its continued support."

The grant-funded work draws on the same silicon and AI platform Exo is developing for handheld ultrasound and OEM-integrated systems, with applications across diagnostic imaging, procedure guidance, therapy, and monitoring.

About Exo
Exo is redefining medical imaging with its advanced ultrasound platform, combining piezoelectric silicon hardware with tightly integrated AI. The platform enables compact, high-performance systems for diagnostic imaging, procedure guidance, and emerging therapeutic applications, expanding access to medical imaging across diverse care settings.

Follow us at @exoeffect on X, LinkedIn, Facebook and Instagram.

For media inquiries, contact [email protected]

Exo Imaging Inc. published this content on November 19, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 15:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]